Loss of VHL (located at chromosome 3p25) is a genomic event observed in >90% of ccRCC patients and is associated with elevated intracellular iron content which may be a critical event in supporting RCC tumorigenesis (52). This evidence concerns the gene VHL and nonpapillary renal cell carcinoma.